Download the case study to understand what three success factors were critical to the rapid launch of this vaccine program during the first month of the COVID-19 outbreak response.
In early March 2020, as the detection of coronavirus began to spread rapidly throughout the United States, Veristat was challenged by a current client to quickly build and launch a database for a novel coronavirus vaccine (nCoV) Phase I trial in healthy volunteers.
The sponsor was ready to go, with two sites and patients already identified. Their gating factor for enrollment was launching the clinical trial database.
Learn how the Veristat team pulled together to quickly design, build, test, and publish the clinical trial database in just two weeks allowing the phase I trial to quickly begin randomizing patients.
Read the case study by completeing the form on the right hand side of this page to learn more.